VIDO-InterVac at the University of Saskatchewan. (Photo: Debra Marshall)

USask’s VIDO-InterVac and the National Research Council of Canada collaborate to advance development of vaccine against COVID-19

Posted on

Key research and development organizations to leverage Canadian expertise and technologies in battle against COVID-19.

The University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) and the National Research Council of Canada (NRC) today announced a collaboration to work together to accelerate the development and production of a candidate COVID-19 antigen in mammalian cells…..
 
Tags:COVID-19HealthResearch

Read More Impact Stories

Posted on

B.C. researchers identify gene that fuels aggressive childhood cancers

For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Read more
Posted on

Researchers develop first COVID-19 rapid test for wastewater

McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Read more
Posted on

World’s most comprehensive study on COVID-19 mental health

Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]
Read more
View All Impact Stories